Hasford, J <br/><br/>
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jun 1998 
 - 850-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/90.11.850  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Blood Cell Count<br/>Europe--epidemiology<br/>Female<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Interferon-alpha--therapeutic use<br/>Japan--epidemiology<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--mortality<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Risk Factors<br/>Severity of Illness Index<br/>Survival Analysis<br/>Survival Rate<br/>United States--epidemiology